Does a normal erythrocyte sedimentation rate (ESR) reliably exclude temporal (giant cell) arteritis?

A Normal ESR Does NOT Reliably Exclude Temporal Arteritis

While raised inflammatory markers are highly sensitive for giant cell arteritis (GCA), a normal ESR should raise suspicion for an alternative diagnosis but cannot definitively exclude GCA—approximately 4-16% of biopsy-proven cases present with normal inflammatory markers 1, 2.

The Evidence on ESR Sensitivity

The 2009 EULAR guidelines explicitly state that "raised inflammatory markers are highly sensitive for the diagnosis of giant cell arteritis" and that "a normal erythrocyte sedimentation rate or C-reactive protein should raise suspicion for an alternative diagnosis" 1. However, this language is carefully chosen—it raises suspicion but does not exclude the diagnosis.

Key Diagnostic Performance Data:

• ESR sensitivity: 82.6-84.1% for GCA diagnosis, meaning 15-18% of cases may have normal ESR 3, 2
• CRP is more sensitive than ESR (86.9% vs 84.1%) 2
• In one large study of 764 patients undergoing temporal artery biopsy, 4% of biopsy-proven GCA cases had both normal ESR and CRP at diagnosis 2
• Studies report 5-30% of histopathologically proven GCA cases may present with normal ESR 4

Clinical Characteristics of GCA with Normal Inflammatory Markers

Patients with GCA and normal inflammatory markers show distinct patterns 2:

• More likely to have polymyalgia rheumatica symptoms
• Less likely to have constitutional symptoms, anemia, or thrombocytosis
• Still respond dramatically to corticosteroid therapy

The Critical Clinical Approach

Do not rely on ESR alone. When GCA is clinically suspected:

1. Obtain BOTH ESR and CRP - concordantly elevated markers increase diagnostic confidence (OR 3.06), while concordantly normal markers reduce but do not eliminate suspicion (OR 0.49) 2

2. Proceed with temporal artery biopsy based on clinical suspicion, even with normal inflammatory markers 1, 5

3. Start high-dose glucocorticoids immediately if clinical suspicion is strong, regardless of ESR results, due to risk of irreversible vision loss 1, 6

4. Consider additional testing: The 2021 ACR/Vasculitis Foundation guidelines conditionally recommend temporal artery ultrasound or vascular imaging as complementary tools when available 5

The Stakes: Why This Matters

Visual loss occurs in 14-18% of GCA patients at diagnosis and is usually irreversible 1, 7. Delaying diagnosis based solely on a normal ESR can result in permanent blindness 8, 9. The 2021 AHA/ASA stroke guidelines emphasize that practitioners should maintain "high index of clinical suspicion" and that laboratory testing combined with compatible clinical presentation may be the only elements needed to initiate treatment 6.

Common Pitfall to Avoid:

Never use a normal ESR as the sole criterion to exclude GCA. Multiple case reports document biopsy-proven GCA with ESR values as low as 17-27 mm/h 9, 10. The clinical presentation—new headache, temporal artery abnormalities, jaw claudication, visual symptoms—must drive the diagnostic workup, not the ESR alone.

Practical Algorithm:

• High clinical suspicion + normal ESR/CRP → Proceed with biopsy and consider starting treatment
• Moderate clinical suspicion + normal ESR/CRP → Check both markers, consider imaging (ultrasound if expertise available), maintain close follow-up
• Low clinical suspicion + normal ESR/CRP → Consider alternative diagnoses but remain vigilant

The bottom line: Clinical judgment supersedes laboratory values in GCA diagnosis, and treatment should never be withheld solely because of normal inflammatory markers when the clinical picture is compelling 1, 5, 2.